牛・豚・豚の生殖器疾患市場：疾患タイプ別、動物タイプ別、診断タイプ別、治療タイプ別、予防・管理別、エンドユーザー別-2025-2030年世界予測

牛・豚・豚の生殖器疾患市場の2024年の市場規模は7億7,972万米ドルで、2025年には8億1,933万米ドルに成長し、CAGRは5.29%、2030年には10億6,253万米ドルに達すると予測されています。

世界の畜産業界は、牛や豚の繁殖病との闘いの中で、かつてない課題と機会に直面しています。技術の急速な進歩と疫学的パターンの進化によって定義される時代において、利害関係者は疾病管理へのアプローチを見直す必要に迫られています。本レポートではまず、繁殖病について包括的に理解し、家畜の生産性、経済の安定性、そしてサプライチェーン全体への影響について詳述します。この分析では、新興の病原体と従来の課題との相互関係を浮き彫りにし、業界の専門家が革新的な戦略を採用するよう促しています。世界化の進展、規制の枠組みの進化、技術の飛躍的進歩といった背景が、我々の議論の背景となっています。また、集約的農業経営、研究機関、獣医学サービスプロバイダーなど、さまざまな部門が直面する多様な課題を認識し、地域の特殊性とより広範な業界のダイナミズムの両方を尊重したオーダーメイドの解決策を求める。このイントロダクションは、現在の情勢を徹底的に概観することで、変革的なシフト、主要なセグメンテーションに関する洞察、そして意思決定者がインパクトのある変革を推進するために必要な知識を身につけるための戦略的提言について、より深く掘り下げるための土台を築くものです。

牛・豚・豚の生殖器疾患市場の変革

近年、牛と豚の生殖医療の領域において、変革的な変化が起きています。デジタルツールや精密な診断方法の急速な普及により、疾病発生の検出と管理方法が再定義されました。最新の画像診断技術や分子アッセイは従来の診断法を補い、感染の拡大を抑制する早期介入戦略を後押ししています。さらに、進化したバイオセキュリティ・プロトコルは、病原体の導入を制限するだけでなく、家畜集団の回復力を高めています。高度なデータ分析と機械学習の統合により、予測モデリングへの道が開かれ、従来の消極的な対策に代わる積極的な対策が提供されています。この進化は、世界の規制改革によってさらに影響を受けています。業界の利害関係者は現在、リスクを軽減することを目的とした調査や協力体制への投資に積極的になっています。革新的な治療レジメンとともにワクチン接種プログラムが強化されたことで、状況はさらに大きく変化し、新興および流行中の疾病に効果的に対処できるようになりました。全体として、このような大きな変化は、機敏性と即応性のある戦略の重要性を強調するものであり、孤立した介入から、最新のテクノロジーと統合的な健康管理の実践力を活用した包括的でデータ主導のアプローチへの転換を求めるものです。

標的疾患管理の主要なセグメンテーション洞察

詳細なセグメンテーション調査により、生殖器疾患のさまざまな側面がどのように進化しているかが明らかになりました。疾患の種類を考慮する場合、市場は細菌感染、真菌感染、寄生虫感染、ウイルス感染を含む分類によって徹底的に調査されます。細菌感染症では、ブルセラ症、レプトスピラ症、結核などが、その経済的影響の大きさから注目されています。真菌の課題には皮膚糸状菌症や真菌中毒症があり、コクシジウム症、トキソプラズマ症、トリインフルエンザなどの寄生虫症は、診断や介入プロトコルを形成する上で極めて重要です。口蹄疫、豚繁殖・呼吸器症候群、豚フィーバーに代表されるウイルス感染症は、強固な管理対策を必要とする絶え間ない脅威となっています。

さらなるセグメンテーションは、牛と豚を区別し、動物の種類に基づいて市場を分類することによって達成されます。ここでは、肉牛と乳牛を繁殖豚、仕上豚、育児豚と区別して取り上げているが、この区分は特定の管理・治療プロトコルを考案する上で極めて重要です。分析は診断技術にまで及び、培養法、画像診断、PCRやLAMPアッセイのような分子生物学的手法、AGID、ELISA、SNTのような血清学的検査が、正確な疾病同定のための詳細なロードマップを提供します。治療戦略は、代替療法、抗生物質、抗寄生虫薬、抗ウイルス薬を含む医薬介入、外科的介入、ワクチン接種に分解されます。さらに、予防と管理に基づく市場セグメンテーションでは、バイオセキュリティ対策、繁殖管理、衛生プロトコル、栄養計画の重要性が強調されています。農場、調査機関、動物病院を含むエンドユーザー別のセグメンテーションは、効果的な疾病管理に必要な戦略的アプローチをさらに洗練させる。これらの洞察は共に、生殖器疾患の多様な状況における特定の課題に対処する、的を絞った戦略のためのバックボーンを形成します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肉や乳製品に対する世界の需要の増加により、効果的な疾病管理の必要性が高まっています。
    • 家畜集団における感染症の蔓延防止に重点を置いたバイオセキュリティ対策の強化
    • 農家の間で効果的な病気予防法の導入に対する意識が高まっている
  • 抑制要因
    • 獣医サービスと生殖疾患の治療にかかる高額な費用
  • 機会
    • 疾病管理ソリューションを強化する製薬会社と農業部門の継続的なパートナーシップ
    • AIを活用したツールによる診断の強化により、牛や豚の健康問題に対する迅速な結果を提供
  • 課題
    • 農村部では獣医サービスへのアクセスが限られており、効果的な疾病管理が制限されています。
• 市場セグメンテーション分析
  • エンドユーザー：調査機関における牛と豚の生殖保健の継続的な進歩
  • 病気の種類：ブルセラ症、レプトスピラ症、結核が牛や豚の生殖疾患に与える影響に関する調査が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 牛・豚・豚の生殖器疾患市場：疾患タイプ別

• 細菌感染症
  • ブルセラ症
  • レプトスピラ症
  • 結核
• 真菌感染症
  • 皮膚糸状菌症
  • 真菌中毒症
• 寄生虫感染
  • コクシジウム症
  • トキソプラズマ症
  • 旋毛虫症
• ウイルス感染
  • 口蹄疫
  • 豚繁殖呼吸器症候群（PRRS）
  • 豚コレラ

第7章 牛・豚・豚の生殖器疾患市場動物の種類別

• 牛
  • 肉牛
  • 乳牛
• 豚
  • 豚の飼育
  • 肥育豚
  • 養豚場の豚

第8章 牛・豚・豚の生殖器疾患市場診断タイプ別

• 培養技術
  • 細菌培養
  • ウイルス分離
• 診断画像
  • 超音波検査
  • X線画像
• 分子的方法
  • LAMPアッセイ
  • PCR
• 血清学的検査
  • AGID
  • エリサ
  • SNT

第9章 牛・豚・豚の生殖器疾患市場治療の種類別

• 代替療法
  • ハーブ療法
  • ホメオパシー
• 医薬品
  • 抗生物質
  • 駆虫薬
  • 抗ウイルス薬
• 外科的介入
  • 矯正手術
  • 予防手術
• 予防接種
  • 不活化ワクチン
  • 生弱毒化ワクチン

第10章 牛・豚・豚の生殖器疾患市場予防と管理

• バイオセキュリティ対策
  • 消毒方法
  • 検疫プロトコル
• 繁殖管理
  • 人工授精技術
  • 遺伝子選択プログラム
• 衛生管理
  • 衛生プロトコル
  • 廃棄物管理
• 栄養管理
  • バランスのとれた食事プラン
  • 有機飼料の選択肢

第11章 牛・豚・豚の生殖器疾患市場：エンドユーザー別

• 農場
• 調査機関
• 獣医クリニック

第12章 南北アメリカの牛・豚・豚の生殖器疾患市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の牛・豚・豚の生殖器疾患市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの牛・豚・豚の生殖器疾患市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Anicon Labor GmbH
• Biogenesis Bago SA
• Biomin Holding GmbH
• Boehringer Ingelheim Animal Health
• CEVA Sante Animale
• Dechra Pharmaceuticals PLC
• Eco Animal Health Group plc
• Elanco Animal Health Incorporated
• Hipra
• Huvepharma EOOD
• Huvepharma Inc.
• IDEXX Laboratories, Inc.
• Innovacyn, Inc.
• Kaneka Corporation（via subsidiary）
• Medovent GmbH
• Merck Animal Health
• MSD Animal Health
• Neogen Corporation
• Norbrook Laboratories Ltd.
• Vetoquinol Global
• Virbac S.A.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET MULTI-CURRENCY
• FIGURE 2. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET MULTI-LANGUAGE
• FIGURE 3. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET RESEARCH PROCESS
• FIGURE 4. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 23. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 29. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET DYNAMICS
• TABLE 7. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BRUCELLOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LEPTOSPIROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DERMATOPHYTOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MYCOTOXICOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COCCIDIOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TOXOPLASMOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TRICHINOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FOOT AND MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING SWINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FINISHING PIGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NURSERY PIGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL CULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL ISOLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ULTRASONOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LAMP ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY AGID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SNT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HERBAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HOMOEOPATHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 65. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 66. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CORRECTIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 67. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PROPHYLACTIC SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 68. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 69. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 70. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 71. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 72. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
• TABLE 73. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
• TABLE 74. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 75. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISINFECTION PRACTICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 76. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY QUARANTINE PROTOCOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 77. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
• TABLE 78. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 79. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ARTIFICIAL INSEMINATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 80. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY GENETIC SELECTION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 81. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 82. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 83. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SANITATION PROTOCOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 84. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY WASTE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 85. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 86. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 87. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BALANCED DIET PLANS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 88. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ORGANIC FEED OPTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 89. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 90. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FARMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 92. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 93. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 94. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 96. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 97. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
• TABLE 98. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 99. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 100. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
• TABLE 101. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
• TABLE 102. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 103. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 104. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 105. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
• TABLE 106. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
• TABLE 107. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
• TABLE 109. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 110. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 111. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
• TABLE 112. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
• TABLE 113. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
• TABLE 114. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 115. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 116. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 117. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 119. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 120. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 121. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 122. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
• TABLE 123. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 124. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 125. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
• TABLE 126. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
• TABLE 127. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 129. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 130. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
• TABLE 131. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
• TABLE 132. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
• TABLE 134. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 135. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 136. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
• TABLE 137. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
• TABLE 138. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
• TABLE 139. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 140. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 141. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 142. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 145. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 146. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
• TABLE 147. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 148. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 149. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
• TABLE 150. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
• TABLE 151. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 152. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 153. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 154. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
• TABLE 155. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
• TABLE 156. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
• TABLE 158. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 159. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 160. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
• TABLE 161. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
• TABLE 162. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
• TABLE 163. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 164. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 165. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 166. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 168. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 169. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 170. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
• TABLE 171. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 172. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 173. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
• TABLE 174. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
• TABLE 175. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 176. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 177. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 178. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
• TABLE 179. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
• TABLE 180. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
• TABLE 182. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 183. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 184. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
• TABLE 185. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
• TABLE 186. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
• TABLE 187. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 188. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 189. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 190. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 192. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 193. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 194. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
• TABLE 195. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 196. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 197. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
• TABLE 198. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
• TABLE 199. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 200. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 201. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 202. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
• TABLE 203. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
• TABLE 204. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 205. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
• TABLE 206. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 207. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 208. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
• TABLE 209. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
• TABLE 210. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
• TABLE 211. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 212. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 213. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 214. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 216. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 217. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 218. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
• TABLE 219. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 220. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 221. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
• TABLE 222. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
• TABLE 223. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 224. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 225. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 226. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
• TABLE 230. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
• TABLE 234. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 236. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 237. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 238. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 240. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 241. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 242. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 243. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
• TABLE 244. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
• TABLE 245. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 246. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
• TABLE 247. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
• TABLE 248. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 249. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 250. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 251. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
• TABLE 252. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
• TABLE 253. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
• TABLE 255. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 256. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 257. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
• TABLE 258. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
• TABLE 259. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
• TABLE 260. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 261. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 262. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 263. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 264. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUN

The Cattle & Porcine/Swine Reproductive Diseases Market was valued at USD 779.72 million in 2024 and is projected to grow to USD 819.33 million in 2025, with a CAGR of 5.29%, reaching USD 1,062.53 million by 2030.

The global livestock industry is confronting unprecedented challenges and opportunities as it grapples with reproductive diseases in cattle and swine. In an era defined by rapid technological advancements and evolving epidemiological patterns, stakeholders are compelled to reassess their approaches to disease management. This report opens by establishing a comprehensive understanding of reproductive diseases, elaborating on their impacts on animal productivity, economic stability, and the overall supply chain. The analysis highlights the interplay between emerging pathogens and traditional challenges, encouraging industry experts to adopt innovative strategies. A backdrop of intensified globalization, evolving regulatory frameworks, and technological breakthroughs serves as the context for our discussion. We also acknowledge the diverse challenges faced by different sectors, whether intensive farming operations, research institutions, or veterinary service providers, calling for tailored solutions that respect both regional specificities and the broader industry dynamic. By presenting a thorough overview of the current landscape, this introduction lays the groundwork for a deeper exploration of transformative shifts, key segmentation insights, and strategic recommendations designed to equip decision-makers with the knowledge necessary to drive impactful change.

Transformative Shifts in the Reproductive Disease Landscape

Recent years have ushered in transformative shifts within the realm of reproductive health in cattle and swine. Rapid adoption of digital tools and precise diagnostic methods has redefined how disease outbreaks are detected and managed. Modern imaging techniques and molecular assays have supplemented traditional diagnostics, empowering early intervention strategies that curb the spread of infections. Moreover, evolving biosecurity protocols are not only limiting the introduction of pathogens, but also enhancing the resilience of livestock populations. The integration of advanced data analytics and machine learning has paved the way for predictive modeling, offering a proactive alternative to conventional reactive measures. This evolution is further influenced by global regulatory reforms, which are pushing for standardized practices across different regions. Industry stakeholders are now more willing to invest in research and collaborative frameworks aimed at mitigating risks. Enhanced vaccination programs alongside innovative treatment regimens have further restructured the landscape, ensuring that both emerging and endemic diseases are countered effectively. Overall, these sweeping changes underscore the importance of agility and responsive strategies, and call for a shift from isolated interventions to comprehensive, data-driven approaches that harness the power of modern technology and integrated health management practices.

Key Segmentation Insights for Targeted Disease Management

An in-depth segmentation study provides clarity on how different facets of reproductive diseases are evolving. When considering disease type, the market is thoroughly studied through classifications that include bacterial, fungal, parasitic, and viral infections. Within bacterial infections, conditions such as brucellosis, leptospirosis, and tuberculosis demand focused attention due to their significant economic impact. Fungal challenges include dermatophytosis and mycotoxicosis, while parasitic infestations such as coccidiosis, toxoplasmosis, and trichinosis are critical in shaping the diagnostic and intervention protocols. Viral infections, exemplified by Foot and Mouth Disease, Porcine Reproductive and Respiratory Syndrome, and Swine Fever, pose a constant threat that necessitates robust control measures.

Further segmentation is achieved by categorizing the market based on animal type, differentiating between cattle and swine. Here, beef and dairy cattle are addressed separately from breeding swine, finishing pigs, and nursery pigs-a delineation that is crucial for devising specific management and treatment protocols. The analysis extends to diagnostic techniques where culturing methods, diagnostic imaging, molecular methods like PCR and LAMP assays, and serological tests such as AGID, ELISA, and SNT provide a detailed roadmap for accurate disease identification. Treatment strategies are dissected into alternative therapies, pharmaceutical interventions including antibiotics, antiparasitics and antivirals, surgical interventions, and vaccinations. Additionally, market segmentation based on prevention and control underscores the importance of biosecurity measures, breeding management, hygiene protocols, and nutrition plans. The segmentation by end-user, which includes farms, research institutions, and veterinary clinics, further refines the strategic approach required for effective disease management. Together, these insights form the backbone for targeted strategies that address specific challenges across the diverse landscape of reproductive diseases.

Based on Disease Type, market is studied across Bacterial Infections, Fungal Infections, Parasitic Infestations, and Viral Infections. The Bacterial Infections is further studied across Brucellosis, Leptospirosis, and Tuberculosis. The Fungal Infections is further studied across Dermatophytosis and Mycotoxicosis. The Parasitic Infestations is further studied across Coccidiosis, Toxoplasmosis, and Trichinosis. The Viral Infections is further studied across Foot And Mouth Disease, Porcine Reproductive And Respiratory Syndrome (PRRS), and Swine Fever.

Based on Animal Type, market is studied across Cattle and Swine. The Cattle is further studied across Beef Cattle and Dairy Cattle. The Swine is further studied across Breeding Swine, Finishing Pigs, and Nursery Pigs.

Based on Diagnosis Type, market is studied across Culturing Techniques, Diagnostic Imaging, Molecular Methods, and Serological Tests. The Culturing Techniques is further studied across Bacterial Culture and Viral Isolation. The Diagnostic Imaging is further studied across Ultrasonography and X-Ray Imaging. The Molecular Methods is further studied across LAMP Assays and PCR. The Serological Tests is further studied across AGID, ELISA, and SNT.

Based on Treatment Type, market is studied across Alternative Therapies, Pharmaceuticals, Surgical Interventions, and Vaccinations. The Alternative Therapies is further studied across Herbal Treatments and Homoeopathy. The Pharmaceuticals is further studied across Antibiotics, Antiparasitics, and Antivirals. The Surgical Interventions is further studied across Corrective Surgeries and Prophylactic Surgeries. The Vaccinations is further studied across Inactivated Vaccines and Live Attenuated Vaccines.

Based on Prevention And Control, market is studied across Biosecurity Measures, Breeding Management, Hygiene Management, and Nutritional Management. The Biosecurity Measures is further studied across Disinfection Practices and Quarantine Protocols. The Breeding Management is further studied across Artificial Insemination Techniques and Genetic Selection Programs. The Hygiene Management is further studied across Sanitation Protocols and Waste Management. The Nutritional Management is further studied across Balanced Diet Plans and Organic Feed Options.

Based on End-User, market is studied across Farms, Research Institutions, and Veterinary Clinics.

Key Regional Insights Across Global Markets

Understanding the regional nuances is integral in crafting strategies that align with local demands and operational challenges. In the Americas, robust animal health frameworks and advanced agricultural practices underscore the importance of continuous innovation in mitigating disease impacts. The Americas serve as a benchmark for integrating cutting-edge diagnostics and treatment protocols, with substantial investments in research and development. In contrast, the combined market regions of Europe, the Middle East, and Africa illustrate a unique blend of historical disease challenges and modern interventions. These regions are characterized by diverse regulatory environments and a varied prevalence of reproductive diseases that call for flexible yet comprehensive management strategies. Meanwhile, the Asia-Pacific region, with its rapid industrial growth and evolving farming techniques, is marked by a rising demand for advanced biosecurity measures and sustainable disease prevention programs. The dynamic nature of each geographical segment necessitates localized studies that consider market-specific disease profiles, regulatory differences, and evolving epidemiological patterns, thus providing a holistic view of the global landscape. Each region's unique approach not only offers lessons in strategic adaptability but also underscores the potential for collaborative innovation in tackling pervasive reproductive health challenges.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Steering Innovation and Market Growth

The market is driven by a competitive landscape that features a range of global and regional leaders, each contributing through innovative research and robust product portfolios. Prominent players such as Anicon Labor GmbH and Biogenesis Bago SA are at the forefront of developing advanced diagnostics and treatment methodologies tailored to reproductive diseases. Entities like Biomin Holding GmbH and Boehringer Ingelheim Animal Health continue to set benchmarks in vaccine development and comprehensive disease management strategies. CEVA Sante Animale and Dechra Pharmaceuticals PLC have been instrumental in bridging scientific research with practical implementation, while Eco Animal Health Group plc and Elanco Animal Health Incorporated consistently lead in deploying next-generation health solutions. Notable companies including Hipra, Huvepharma EOOD, and Huvepharma Inc. harness cutting-edge research to push the boundaries of disease prevention and control. IDEXX Laboratories, Inc. alongside Innovacyn, Inc. have built strong reputations through innovative diagnostic technologies, further enhanced by the contributions of Kaneka Corporation via its subsidiaries and Medovent GmbH. Industry giants like Merck Animal Health, MSD Animal Health, Neogen Corporation, Norbrook Laboratories Ltd., Vetoquinol Global, Virbac S.A., and Zoetis Inc. round out the competitive spectrum, consistently raising the bar for quality and efficacy. Their collaborative efforts reflect the dynamism within this sector and highlight a commitment to leveraging innovation to effectively address current and future challenges in reproductive disease management.

The report delves into recent significant developments in the Cattle & Porcine/Swine Reproductive Diseases Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH, Biogenesis Bago SA, Biomin Holding GmbH, Boehringer Ingelheim Animal Health, CEVA Sante Animale, Dechra Pharmaceuticals PLC, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Hipra, Huvepharma EOOD, Huvepharma Inc., IDEXX Laboratories, Inc., Innovacyn, Inc., Kaneka Corporation (via subsidiary), Medovent GmbH, Merck Animal Health, MSD Animal Health, Neogen Corporation, Norbrook Laboratories Ltd., Vetoquinol Global, Virbac S.A., and Zoetis Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to adopt a multi-pronged approach that integrates advanced diagnostic and treatment methodologies with preventative and sustainable management practices. A strategic investment in research aimed at early detection and rapid response protocols is paramount, as is the expansion of collaborative networks that bring together cross-disciplinary expertise. It is essential to harness precise data analytics, deploying predictive modeling tools to forecast disease outbreaks and streamline intervention strategies. Investing in modern technology and digital transformation not only enhances operational efficiency but also strengthens the resilience of health management frameworks. Leaders should also focus on adapting their strategies to suit diverse market segments, considering the unique disease profiles and operational challenges specific to cattle versus swine, and northern as well as emerging markets. Emphasis on continuous training and robust communication channels among veterinary teams will ensure that innovations in diagnosis and treatment are effectively implemented. Furthermore, fostering partnerships with academic institutions and research bodies can drive novel insights and refine best practices in disease management. By embracing these recommendations, decision-makers can better mitigate the impending risks associated with reproductive diseases while optimizing the overall productivity and sustainability of the livestock industry.

Conclusion: Charting the Future of Disease Management

In conclusion, the landscape of reproductive diseases in cattle and swine is characterized by rapid scientific and technological evolution, which provides both remarkable opportunities and significant challenges. The integration of advanced diagnostics, segmented approaches to disease management, and regional nuances have collectively set the stage for a more proactive and precise strategy in combating these health issues. Companies leading the charge with innovative solutions are redefining the metrics of success within this competitive market. Although the challenges remain formidable, the emerging trends in early detection, targeted therapy, and robust prevention protocols inspire a confident outlook for the future. This comprehensive analysis reinforces the need for cohesive, data-driven, and forward-thinking approaches that can adapt to the evolving disease landscape. Moving forward, stakeholders must collaborate strategically, investing in technology and partnerships that not only ensure animal health and productivity but also safeguard the economic vitality of the livestock industry.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing global demand for meat and dairy products is driving the need for effective disease management
    • 5.1.1.2. Rising in biosecurity measures focus on preventing the spread of infectious diseases in livestock populations
    • 5.1.1.3. Growing awareness among farmers enhancing the adoption of effective disease prevention methods
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of veterinary services and treatments for reproductive diseases
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing partnerships between pharmaceutical companies and agricultural sectors enhancing disease control solutions
    • 5.1.3.2. Enhancing diagnostics through AI-driven tools to provide rapid results for cattle and porcine health issues
  • 5.1.4. Challenges
    • 5.1.4.1. Limited access to veterinary services in rural areas restricts effective disease management
• 5.2. Market Segmentation Analysis
  • 5.2.1. End-User: Ongoing advancement of cattle & swine reproductive health in research institutions
  • 5.2.2. Disease Type: Growing research on the impact of Brucellosis, Leptospirosis, and Tuberculosis on Cattle & Porcine Reproductive Diseases
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cattle & Porcine/Swine Reproductive Diseases Market, by Disease Type

• 6.1. Introduction
• 6.2. Bacterial Infections
  • 6.2.1. Brucellosis
  • 6.2.2. Leptospirosis
  • 6.2.3. Tuberculosis
• 6.3. Fungal Infections
  • 6.3.1. Dermatophytosis
  • 6.3.2. Mycotoxicosis
• 6.4. Parasitic Infestations
  • 6.4.1. Coccidiosis
  • 6.4.2. Toxoplasmosis
  • 6.4.3. Trichinosis
• 6.5. Viral Infections
  • 6.5.1. Foot And Mouth Disease
  • 6.5.2. Porcine Reproductive And Respiratory Syndrome (PRRS)
  • 6.5.3. Swine Fever

7. Cattle & Porcine/Swine Reproductive Diseases Market, by Animal Type

• 7.1. Introduction
• 7.2. Cattle
  • 7.2.1. Beef Cattle
  • 7.2.2. Dairy Cattle
• 7.3. Swine
  • 7.3.1. Breeding Swine
  • 7.3.2. Finishing Pigs
  • 7.3.3. Nursery Pigs

8. Cattle & Porcine/Swine Reproductive Diseases Market, by Diagnosis Type

• 8.1. Introduction
• 8.2. Culturing Techniques
  • 8.2.1. Bacterial Culture
  • 8.2.2. Viral Isolation
• 8.3. Diagnostic Imaging
  • 8.3.1. Ultrasonography
  • 8.3.2. X-Ray Imaging
• 8.4. Molecular Methods
  • 8.4.1. LAMP Assays
  • 8.4.2. PCR
• 8.5. Serological Tests
  • 8.5.1. AGID
  • 8.5.2. ELISA
  • 8.5.3. SNT

9. Cattle & Porcine/Swine Reproductive Diseases Market, by Treatment Type

• 9.1. Introduction
• 9.2. Alternative Therapies
  • 9.2.1. Herbal Treatments
  • 9.2.2. Homoeopathy
• 9.3. Pharmaceuticals
  • 9.3.1. Antibiotics
  • 9.3.2. Antiparasitics
  • 9.3.3. Antivirals
• 9.4. Surgical Interventions
  • 9.4.1. Corrective Surgeries
  • 9.4.2. Prophylactic Surgeries
• 9.5. Vaccinations
  • 9.5.1. Inactivated Vaccines
  • 9.5.2. Live Attenuated Vaccines

10. Cattle & Porcine/Swine Reproductive Diseases Market, by Prevention And Control

• 10.1. Introduction
• 10.2. Biosecurity Measures
  • 10.2.1. Disinfection Practices
  • 10.2.2. Quarantine Protocols
• 10.3. Breeding Management
  • 10.3.1. Artificial Insemination Techniques
  • 10.3.2. Genetic Selection Programs
• 10.4. Hygiene Management
  • 10.4.1. Sanitation Protocols
  • 10.4.2. Waste Management
• 10.5. Nutritional Management
  • 10.5.1. Balanced Diet Plans
  • 10.5.2. Organic Feed Options

11. Cattle & Porcine/Swine Reproductive Diseases Market, by End-User

• 11.1. Introduction
• 11.2. Farms
• 11.3. Research Institutions
• 11.4. Veterinary Clinics

12. Americas Cattle & Porcine/Swine Reproductive Diseases Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Cattle & Porcine/Swine Reproductive Diseases Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Merck Animal Health launch SENSEHUB cow calf for enhanced breeding success
  • 15.3.2. NutriQuest and Modulant Biosciences partner to innovate swine disease control
  • 15.3.3. EpiVax and Zoetis collaborate to enhance swine vaccine effectiveness with CircoMatch tool
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Anicon Labor GmbH
• 2. Biogenesis Bago SA
• 3. Biomin Holding GmbH
• 4. Boehringer Ingelheim Animal Health
• 5. CEVA Sante Animale
• 6. Dechra Pharmaceuticals PLC
• 7. Eco Animal Health Group plc
• 8. Elanco Animal Health Incorporated
• 9. Hipra
• 10. Huvepharma EOOD
• 11. Huvepharma Inc.
• 12. IDEXX Laboratories, Inc.
• 13. Innovacyn, Inc.
• 14. Kaneka Corporation (via subsidiary)
• 15. Medovent GmbH
• 16. Merck Animal Health
• 17. MSD Animal Health
• 18. Neogen Corporation
• 19. Norbrook Laboratories Ltd.
• 20. Vetoquinol Global
• 21. Virbac S.A.
• 22. Zoetis Inc.